Better antibiotic prophylaxis for hip and knee replacement surgery ?
Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents
J Arthroplasty. 2010 Oct;25(7):1078-82435 patients with hip or knee OA scheduled to undergo total joint replacement were randomized to receive one of the three empirical iv antibiotic treatments.The study aimed to compare the efficacy of these three antibiotics in reducing methicillin-resistant Staphylococcus aureus (MRSA) andmethicillin-resistant Staphylococcus epidermidis (MRSE) infections. At the completion of minimum observation period of 24 months, it was concluded that the specific antistaphylococcal agents (Vancomycin and Fusidic Acid) did not provide better antibiotic prophylaxis than broad-spectrum agents (Cefuroxime) in primary joint replacement surgery (TKA or THA).
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
